ask="3.75"
ask_size="800"
average_daily_volume="166665"
bid="3.71"
bid_size="300"
book_value="-0.04"
change="+0.31"
change_from_200_day_moving_average="0.63"
change_from_50_day_moving_average="0.82"
change_from_52_week_high="-2.01"
change_From_52_week_low="2.16"
change_in_percent="+8.93%"
close="3.78"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.34"
ebitda="-14.10M"
eps_estimate_current_year="-0.20"
eps_estimate_next_quarter="0.00"
eps_estimate_next_year="-0.57"
ex_dividend_date="N/A"
float_shares="28680000"
high="4.00"
high_52_weeks="5.79"
last_trade_date="2/6/2017"
last_trade_price="3.78"
last_trade_size="787"
last_trade_time="4:00pm"
low="3.50"
low_52_weeks="1.62"
market_capitalization="180.97M"
moving_average_200_day="3.15"
moving_average_50_day="2.96"
name="Nymox Pharmaceutical Corporatio"
notes="N/A"
one_year_target_price="10.25"
open="3.50"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+19.98%"
percent_change_from_50_day_moving_average="+27.90%"
percent_change_from_52_week_high="-34.72%"
percent_change_from_52_week_low="+133.33%"
previous_close="3.47"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="N/A"
price_per_sales="522.57"
revenue="317900.00"
shares_outstanding="47875000"
short_ratio="19.29"
stock_exchange="NCM"
symbol="NYMX"
volume="774572"
weeks_range_52="1.62 - 5.79"
